Thursday - October 01, 2026

Category Archives: Science

Wet-AMD Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight

DelveInsight’s “Wet-AMD Pipeline Insight 2026” report provides comprehensive insights about 60+ companies and 75+ pipeline drugs in the Wet-AMD pipeline landscape. It covers the Wet-AMD Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Wet-AMD Pipeline … Continue reading →

T-Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 90+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “T-Cell Lymphoma Pipeline Insight, 2026” report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in T-Cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment … Continue reading →

Global Cancer Biomarkers Market to Reach $42.0 Billion by 2029

Cancer Biomarkers Market by Profiling Technology (Omics, Imaging), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Product (Instruments, Consumables), Application (Diagnostics, R&D, Prognostics), End-user, and Region – Global Forecast to 2029 According to MarketsandMarkets™, The report “Cancer Biomarkers Market by Profiling Technology … Continue reading →

Ulcerative Colitis Treatment Pipeline Shows Strong Momentum as 70+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Ulcerative Colitis Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Ulcerative Colitis Pipeline Landscape. It covers the Ulcerative Colitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Type 1 Diabetes Clinical Trial Pipeline Shows Potential with Active Contributions from 85+ Key Companies | DelveInsight

DelveInsight’s, “Type 1 Diabetes Pipeline Insight, 2026” report provides comprehensive insights about 85+ companies and 100+ pipeline drugs in Type 1 Diabetes pipeline landscape. It covers the Type 1 Diabetes pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

TCR Therapy Clinical Trial Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “TCR Therapy Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the TCR Therapy pipeline landscape. It covers the TCR Therapy pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum: 120+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Systemic Lupus Erythematosus Pipeline Insights 2026” report provides comprehensive insights about 120+ companies and 140+ pipeline drugs in Systemic Lupus Erythematosus pipeline landscape. It covers the Systemic Lupus Erythematosus pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Former Ontario Ministry of Health Chief Architect Hugo Raposo Discusses How AI Is Transforming Canada’s Healthcare Systems

Artificial intelligence is becoming the digital foundation of modern healthcare systems. By connecting data, clinicians, and intelligent platforms, we can transform how care is delivered and improve health outcomes across entire populations. Artificial intelligence is redefining the future of healthcare … Continue reading →

Type 2 Diabetes Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Type 2 Diabetes Pipeline Insight, 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Type 2 Diabetes pipeline landscape. It covers the Type 2 Diabetes pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Hematology Analyzers and Reagents Market Projected to Reach $8.8 Billion by 2029 Driven by Rising Blood Testing Demand

Hematology Analyzers and Reagents Market by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price (High, Mid, Low), Application (Anemia, Blood Cancer), End User (Hospital, CTL, Govt Lab, Blood Bank) – Global Forecast to 2029 According to MarketsandMarkets™, The report “Hematology … Continue reading →